<?xml version='1.0' encoding='utf-8'?>
<document id="24810214"><sentence text="Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphoma."><entity charOffset="0-10" id="DDI-PubMed.24810214.s1.e0" text="Etravirine" /></sentence><sentence text="The treatment of malignancies in HIV patients is challenged by the issue of drug-drug interactions between antiretroviral therapy and antineoplastic agents" /><sentence text=" While protease inhibitors have been shown to increase the incidence and severity of cancer therapy-related side effects, the impact of other antiretroviral agents on the tolerability and response to chemotherapy is less well documented" /><sentence text=" We report the successful use of an etravirine-based regimen in a patient treated with BEACOPP chemotherapy for advanced Hodgkin's lymphoma"><entity charOffset="36-46" id="DDI-PubMed.24810214.s4.e0" text="etravirine" /></sentence><sentence text=" Etravirine constitutes a valuable option for concomitant use with chemotherapy due to its moderate inducing effect on drug metabolising enzymes"><entity charOffset="1-11" id="DDI-PubMed.24810214.s5.e0" text="Etravirine" /></sentence><sentence text=" " /></document>